CHRONIX BIOMEDICAL, INC

Chronix Biomedical, Inc. is a molecular diagnostics company offering laboratory developed tests for cancer.

CNI Monitor

Provides earliest determination of the efficacy of cancer therapies.

CNI Screen

Can provide indication of a new malignancy and in an asymptomatic individual arise.

CNI 2nd Opinion

Assists in reducing unnecessary biopsies and improves patient care.

All Chronix tests are blood tests (Liquid biopsy tests) which detect tumor-derived cell-free DNA in blood samples of patients. Gains and losses of large chromosome sections that are present in the genome of cancer cells are detected and combined in a comprehensive copy number instability (CNI) score that can indicate tumor existence, remission or progression. Chronix blood tests are suitable for therapy monitoring for patients with chemotherapy or immunotherapy and for relapse monitoring after tumor resection (CNI MONITOR), screening (CNI SCREEN) and/or 2nd opinion regarding eventual tissue biopsis (CNI 2nd OPINION).

DISTRIBUTION CHAIN

Distributor – UK

Emma Lane

Advanced Cancer Diagnostics, Ltd

+44 207 491 5111

28 Bolton Street, London, W1J 8BP

advancedcancerdiagnostics.com

emma.lane@advancedcancerdiagnostics.com

+44 0 207 629 9933

Distributor – Poland

Elżbieta Ginalska-Markiewicz

Modern Cancer Diagnostics

+48 22 646 46 97

Willowa 2/1 00-790 Warszawa

moderncancerdiagnostics.pl

a.markiewicz@moderncancerdiagnostics.com

+48 601 812 775

LBC Logo

LBC is an officially licensed Chronix laboratory offering CNI tests in Europe